ADMA Biologics (ADMA) Reports In-Line Q3 EPS, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| ADMA Biologics Inc Com (NASDAQ: ADMA) | Delayed: 10.48 -0.63 (5.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.11 | 52 Week High | $9.65 | |||
| Open | $11.49 | 52 Week Low | $4.15 | |||
| Day High | $11.49 | P/E | N/A | |||
| Day Low | $10.25 | EPS | $-0.01 | |||
| Volume | 13,141,655 | |||||
